Maximuscle sold to GlaxoSmithKline for £162m

Founder Zef Eisenberg plans to stay on as 'industry ambassador'

Our experts

We are a team of writers, experimenters and researchers providing you with the best advice with zero bias or partiality. This article was authored by:
  • Carys Matthews

Young Gun of 2006, Zef Eisenberg has engineered a successful exit from Maximuscle, the sports nutrition supplier, after reportedly selling the business for £162m to healthcare company GlaxoSmithKline (GSK).

Eisenberg founded the business in 1995 and has seen profits more than double year-on-year, and will stay on as an ‘industry ambassador.'

Maximuscle sold a majority stake of the business to Darwin Private Equity in 2007, while maintaining a significant shareholding. However, following GSK's attractive offer Eisenberg decided the time to sell was now.

Eisenberg said: “We had no intention of selling the business at this time, but GSK approached us quietly with tomorrow's price today.”

 

Carys Matthews

Leave a comment

We value your comments but kindly requests all posts are on topic, constructive and respectful. Please review our commenting policy.

Back to Top